4 unknown, 1 completed, 1 terminated. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Unknown 4, Completed 1, Terminated 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow HAIC: new trials by email Literature Review of HAIC trials Research Report on HAIC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC HAIC, Zoledronic acid - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 264 | 2023-05-10 | 2023-05-19 |
| HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study HAIC, FOLFOX 2d, FOLFOX 1d - Hepatocellular Carcinoma | Phase 3 | Unknown | Sun Yat-sen University | 300 | 2022-07-26 | 2022-12-09 |
| DEB-TACE+HAIC vs. HAIC for Large HCC dTACE-HAIC, HAIC, dTACE-HAIC protocol - Unresectable Hepatocellular Carcinoma | Phase 3 | Unknown | Second Affiliated Hospital of Guangzhou Medical University | 230 | 2022-02-10 | 2023-06-22 |
| Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. HAIC, TACE, FOLFOX - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Terminated | Peking University | 18 | 2021-12-24 | 2025-12-18 |
| Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC Sorafenib, Hepatic arterial infusion chemotherapy, Folfox Protocol - Hepatocellular Carcinoma | Phase 3 | Completed | Sun Yat-sen University | 247 | 2016-05-01 | 2019-12-05 |
| Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection Oxaliplatin(OXA), 5-fluorouracil (5-FU), Hepatic arterial catheter implantation - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | Peking University Cancer Hospital & Institute | 192 | 2015-02-01 | 2017-08-10 |
Sun Yat-sen University (3) · Peking University (1) · Peking University Cancer Hospital & Institute (1) · Second Affiliated Hospital of Guangzhou Medical University (1)
China (6)
Baocai Xing, Doctor (1) · Kangshun Zhu, Dr. (1) · Ming Shi, MD (1) · Xiaodong Wang, MD (1) · Xu Zhu, Doctor (1)
PMID 11981766, PMID 12049862, PMID 12540794, PMID 20686792, PMID 20839057, PMID 21514523, PMID 25742141, PMID 25995680, PMID 31070690, PMID 9149014